Search results
Calgary Prostate Cancer Support Group: Meeting For Patients & Partners Announced
Digital Journal· 4 days agoDr. Gotto shared his expertise and recent contributions to clinical trials for advanced prostate cancer. These addresses are informative and encouraging ...
SHINE Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New...
The Parsons Sun· 2 days agoSHINE Technologies, LLC (SHINE), a pioneer in next-generation fusion-based technology, today announced a new partnership with Blue Earth Therapeutics, a Bracco company and recognized leader ...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 4 days agoOf the 200 cancer drugs approved over the past few years, only three or four were for pediatric ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoMen in the U.S. are currently missing out on opportunities to prevent cancer or detect it early, with 65% reporting they are behind on at least one routine cancer ...
Germany’s ITM raises $205M as radiopharma field booms
BioPharma Dive via Yahoo Finance· 2 days agoUniquely...investment have flown into new startups. Steffen Schuster, the longtime CEO of ITM,...
Roswell Park Earns ‘Exceptional’ Rating from N | Newswise
Newswise· 2 days agoBUFFALO, N.Y. — Roswell Park Comprehensive Cancer Center has earned its most highly rated grant from...
These ultrasound mobile units are helping pregnant women in cities lacking care
CBS News· 1 day agoTo help bridge the gap, the nonprofit has rolled out mobile units with ultrasound capabilities in...
Nucleus RadioPharma secures Series A investment from AstraZeneca
BioPharma-Reporter· 2 days agoThe investment from AstraZeneca marks a strategic move to further expand Nucleus's capabilities in developing targeted radiotherapies and theranostics, aimed at making cancer
ASCO: ConcertAI announces Nvidia partnership, launches new AI tools
FierceBiotech· 6 days ago“Nvidia Enterprise AI solutions are evolving faster than peers to provide the...generative AI and...
...Results For Biodexa's eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have a 100%...
Morningstar· 5 days agoCARDIFF, UK / ACCESSWIRE / June 3, 2024 / Biodexa Pharmaceuticals (NASDAQ:BDRX) just announced promising phase 2 results for its newly in-licensed drug eRapa for treating familial adenomatous ...